10/14/2026
Advancements in glaucoma care are increasingly focused on improving patient convenience and precision. Innovations such as micro-invasive glaucoma surgery (MIGS) and sustained-release medication devices help regulate intraocular pressure steadily without the burden of complex daily drop schedules. Read about the latest breakthroughs in long-acting glaucoma therapies: https://www.brightfocus.org/grant/developing-a-new-glaucoma-treatment-that-avoids-daily-drops/
Our lab has developed an injectable medication for the treatment of glaucoma; we seek to further evaluate this treatment in a clinically relevant model.